Back to News
Health & Wellness
Nov 8, 202626 views2 min read

NIH-Funded Study Links Brown Fat Activity to Lower Risk of Heart Disease, Diabetes, and Depression

A study published in Nature on October 14 found that brown fat activity is linked to lower odds of cardiometabolic and psychiatric diseases in humans. Researchers at Rockefeller University analyzed more than 100,000 patient records. The study also found that the blood pressure drug losartan can activate brown fat in mice.

NIH-Funded Study Links Brown Fat Activity to Lower Risk of Heart Disease, Diabetes, and Depression

A study published in Nature on October 14, 2026, found that brown fat activity is associated with lower risks of heart disease, type 2 diabetes, and psychiatric conditions including depression and anxiety.

Researchers at Rockefeller University, led by Dr. Paul Cohen, analyzed more than 100,000 patient records. They compared nearly 9,000 patients with brown fat activity against more than 17,000 patients without it. The study was funded by the National Institutes of Health.

Brown fat burns energy to produce heat, unlike white fat, which stores energy. It is found deep in the neck, thorax, armpits, and along the spine. The amount of brown fat in humans varies by age, sex, and body-mass index.

The researchers found that higher total brown fat activity was linked to lower odds of type 2 diabetes, atrial fibrillation, coronary heart disease, and congestive heart failure. Brown fat activity was also linked to healthier blood sugar levels, better lipid profiles, and lower inflammation markers.

The team used machine learning to identify these connections across a broad range of health conditions. Previous research had focused mainly on cardiovascular disease. This study expanded the analysis to include psychiatric diagnoses.

"We doubled our number of patients and did an unbiased analysis across all diagnoses, which allowed us to unearth many new insights," Cohen said.

The researchers also found that losartan, a blood pressure drug in the class called angiotensin receptor blockers, increased brown fat activity in cultured cells and in mice. The drug worked through a mechanism separate from its blood pressure effects, suggesting it could potentially be repurposed to activate brown fat in humans.

Related Articles